v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Aug. 31, 2026
May 31, 2026
Aug. 31, 2025
May 31, 2025
Aug. 31, 2026
Aug. 31, 2025
Feb. 28, 2026
CASH FLOWS USED IN OPERATING ACTIVITIES:              
Net loss $ (6,838,473) $ (5,715,838) $ 763,064 $ (4,594,018) $ (12,554,310) $ (3,830,953)  
Adjustments to reconcile net income to net cash used in operating activities:              
Depreciation and amortization         1,114,920 1,012,196  
Bad debts expense         40,000 71,482  
Inventory provision         270,987  
Reduction of right of use asset         77,960 68,809  
Accretion of lease liability         44,627 53,778  
Stock based compensation         94,483 160,710  
Amortization of debt discounts         1,036,482 143,217  
Derivative liability loss         1,495,130  
(Gain) loss on settlement of debt 185,910   (4,370,185)   893,510 (4,370,185)  
Increase (decrease) in related party accrued payroll and interest         (117,239) 67,575  
Changes in operating assets and liabilities:              
Accounts receivable         17,055 364,630  
Prepaid expenses         (76,821) 340,696  
Deposit on right of use asset         (13,187)  
Device parts inventory         (870,327) (1,283,861)  
Accounts payable and accrued expenses         (87,311) 473,931  
Customer deposits         44,312 (7,649)  
Deferred compensation for CEO         140,112 (1,004,917)  
Operating lease liabilities         (121,908) (118,906)  
Current portion of deferred variable payment obligation for payments         619,535 609,067  
Accrued interest payable         3,117,961 1,863,013  
Net cash used in operating activities         (4,820,842) (5,400,554)  
CASH FLOWS USED IN INVESTING ACTIVITIES:              
Purchase of fixed assets         (15,600) (8,422)  
Acquisition of trademarks         (838) (1,998)  
Net cash used in investing activities         (16,438) (10,420)  
CASH FLOWS FROM FINANCING ACTIVITIES:              
Share proceeds net of issuance costs         1,332,722 4,362,349  
Proceeds from loans payable         4,594,328 1,050,671  
Repayment of loans payable         (1,178,538) (420,000)  
Proceeds on issuance of Series C shares         200,000  
Redemption of Series C shares         (125,000)  
Net cash provided by financing activities         4,948,512 4,868,020  
Net change in cash         111,232 (542,954)  
Cash, beginning of period   $ 109,043   $ 865,975 109,043 865,975 $ 865,975
Cash, end of period $ 220,275   $ 323,021   220,275 323,021 $ 109,043
Supplemental disclosure of cash and non-cash transactions:              
Cash paid for interest         21,575 74,338  
Cash paid for income taxes          
Noncash investing and financing activities:              
Transfer from device parts inventory to revenue earning devices         657,002 1,792,348  
Debt discount from derivative liabilities         2,395,452  
Conversion of debt and accrued interest for common shares         149,992  
Conversion of Series C shares for common shares         534,798  
Exchange of note payable for common stock         985,990 2,500,500  
Commitment fee shares as debt discount         202,250  
Right of use asset for lease liability         53,739  
Series C preferred shares issued as dividend         27,413 24,508  
Discount applied to face value of the loan         596,834 251,629  
Series C penalty shares issued         $ 149,307